Allogene Therapeutics, Inc. — Institutional Ownership

Which tracked institutions hold ALLO, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.

20
Funds holding
$119638439
Total value held
Buying
17 added/new · 2 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $46582273 19091095 +1415066 +8.01%
2 Pfizer Inc $30183895 22032040 Held
3 State Street Corp $21131147 8660306 +5898906 +213.62%
4 Goldman Sachs Group Inc $6749636 2766244 +476786 +20.83%
5 Bank Of America Corp /De/ $5208114 2134473 +1127145 +111.89%
6 Northern Trust Corp $3137113 1285702 +87235 +7.28%
7 Morgan Stanley $2437182 998845 +295707 +42.06%
8 Bank Of New York Mellon Corp $964255 395187 -10656 -2.63%
9 Invesco Ltd. $835436 609807 +84494 +16.08%
10 Citigroup Inc $810974 591952 -2147 -0.36%
11 Ameriprise Financial Inc $596804 244592 NEW BUY
12 Barclays Plc $392463 160846 NEW BUY
13 Wells Fargo & Company/Mn $274378 200276 +55415 +38.25%
14 Royal Bank Of Canada $138000 56532 NEW BUY
15 Sei Investments Co $126763 51952 NEW BUY
16 Prudential Financial Inc $61000 25000 NEW BUY
17 Pnc Financial Services Group, Inc. $7459 3057 NEW BUY
18 Us Bancorp \De\ $1396 572 NEW BUY
19 Amalgamated Financial Corp. $85 9350 NEW BUY
20 Toronto Dominion Bank $66 27 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.